Skip to content

Critical Illness / AIA Financial Indonesia

Proteksi Penyakit Kritis Maksima Ekstra (Prima Extra)

Critical Illness agency Full brief · 2026-05-17

Prima Extra is a bank-channel critical-illness lump-sum policy that doubles as a long-dated whole-of-life contract — pay premiums for 5, 10, or 20 years, get protection to age 99, and walk away with a 100% Uang Pertanggungan (sum assured)…

★ The Insurer’s Play

analytical interpretation

Why this product exists

To sell lump-sum protection against a small set of high-cost diagnoses — specifically, to capture whole-household budgets rather than single lives and use a loyalty mechanic to improve persistency and perceived value.

What the insurer wants the agent to do

Steer the agent to bundle several family members onto one policy, lead with the no-claim cashback / loyalty bonus, and attach and upsell supplementary riders.

Inferred from: family-package structureno-claim cashback / loyalty mechanicrider attachmentunit-linked / PAYDI designPOJK 36/2025 co-paymentaffluent / legacy segment

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

✓ Fits when…

  • Age 30–50, BCA primary banking relationship, comfortable with autodebet from BCA savings or BCA credit card
  • Household income Rp 15M+/month; needs to support the minimum Rp 500,000/month premium ticket on a meaningful SA
  • Wants lump-sum critical-illness protection (not health reimbursement) — already has a hospital-cash or health plan separately
  • Family cancer or heart-disease history → values the overseas-treatment window and the relapse benefit
  • Lifestyle that earns Silver/Gold/Platinum Vitality status — runners, gym regulars, smart-watch users. Without Vitality engagement the cashback math doesn't move.
  • Long horizon — sees insurance as a 20-year, age-to-99 commitment, not a 5-year hedge

~ Borderline — qualify carefully

  • Age 51–60 — still eligible, but Premi/SA ratio worsens sharply; only 5-year PPT available at 56–60, which loads the cashflow heavily
  • Customers who want CI cover but bank with Mandiri/BNI/BRI — Prima Extra is BCA-channel; they will need to open a BCA account or pay by BCA credit card for the autodebet
  • Parents buying for children (1 month – 17 years) — works, but the 20% SA payout for diagnoses in the first 90 days post-birth (180 days for death) is an under-discussed dilution most parents miss
  • Customers who already own a Major CI lump-sum policy elsewhere — Prima Extra can layer for the relapse + overseas treatment angle, but is not a clean primary policy stack

✕ Not a fit when…

  • Customers looking for medical reimbursement / hospital cashless — wrong product. Prima Extra pays a lump sum on diagnosis; it does not pay hospital bills directly except for the ICU daily cash and ICU catch-all (which trigger only with invasive ventilation, not standard ICU stays).
  • Customers without basic hospital cover — sell them a medical plan first
  • Customers without USD financial relevance who can't afford the Rp 500K/month minimum — there is no entry-level skinnier variant
  • Anyone uncomfortable with the 80-day waiting period on the CI benefit set — if they're shopping because they recently had a worrying symptom, this is mis-selling territory
  • Customers with pre-existing conditions they have not disclosed — the entire CI benefit set is excluded for pre-existing conditions; non-disclosure creates a repudiation risk

The trade-offs — when it wins, when it doesn’t

No product wins for everyone. Here’s when Proteksi Penyakit Kritis Maksima Ekstra (Prima Extra) is the right call — and when a different product is.

PROSPECT IS BCA-PRIMARY, WANTS CI LUMP-SUM, MODEST SA

Lead:Prima Extra

Distribution moat; autodebet from BCA is frictionless; rivals can't match same-bank UX.

PROSPECT BANKS ELSEWHERE, WANTS COMPREHENSIVE CI

Lead:Allianz Critical+ or Tokio Marine CI

Agency distribution removes the BCA-account friction; rate sheet often competitive at same SA.

PROSPECT VALUES SURVIVAL PAYBACK (RETURN OF SA AT 99)

Lead:Prima Extra

Endowment-style maturity benefit is uncommon in the lump-sum CI peer set.

PROSPECT WANTS CI CASH AND PERMANENT LIFE COVER IN ONE WRAPPER

Lead:Allianz LegacyPro + Critical+ rider

Whole-life chassis with CI premium waiver; cleaner legacy positioning; short-pay flexibility.

PROSPECT'S CONCERN IS CANCER RECURRENCE

Lead:Prima Extra

Minor-cancer relapse pays 25% SA again if histologically distinct >12 months later — peer set rarely codifies this.

PROSPECT IS WEALTHY, WANTS OVERSEAS TREATMENT AS A PRIMARY USE CASE

Lead:Prima Extra (or Tokio Marine equivalent if BCA friction is real)

Overseas treatment benefit (up to 50% SA + USD 200/day) is one of the cleaner formulations in Indonesian CI market.

PROSPECT WANTS LOWEST PREMIUM FOR CI COVER

Lead:Term-CI rider on existing life policy

Prima Extra's whole-of- life chassis loads premium; pure term-CI is 3-5x cheaper per Rp of SA.

PROSPECT IS A FITNESS ENTHUSIAST, USES WEARABLES

Lead:Prima Extra

Vitality cashback is the only mechanism in Indonesian market that monetises Platinum-tier fitness — up to 30%/yr cashback on 20-year PPT.

PROSPECT IS RISK-AVERSE TO INVESTMENT-LINKED

Lead:Prima Extra (it's traditional, not ULIP)

No fund choice, no market exposure; structurally closer to whole-life.

PROSPECT HAS PRE-EXISTING CONDITIONS, SHORT HORIZON

Lead:Walk away

80-day waiting period + pre-existing exclusion block the use case; guaranteed mis-sell.

Key facts

Coverage

  • Sum assured: not disclosed on page
  • Policy term: hingga usia 99 tahun
  • Pricing: not disclosed on page

Target Customer

Not specified on page.

Key Features

  • Asuransi Jiwa AIA Melangkah Bersama AIA PowerPro Life Optima Protection Plus Proteksi Jiwa Maksima (JIMI) AIA Nura Journ
  • AIA Melangkah Bersama
  • AIA PowerPro Life
  • Optima Protection Plus

⚠ Compliance red flags & mis-selling warnings

These are the issues most likely to trigger an OJK complaint or a customer dispute in 2026 under the tightened bancassurance conduct rules. Build agent training around all seven.

  1. POJK 36/2025 co-payment context. POJK 36/2025 brought a 10% co-payment regime into Indonesian health insurance from 2026. Prima Extra is not a health/reimbursement product — it is a lump-sum CI policy, so the co-payment regime does not apply to its benefit payouts. However, BCA frontline staff may incorrectly mention co-payment when describing the product because the BCA training materials cover both health and CI lines. Agents must explicitly correct: Prima Extra pays a defined cash sum on diagnosis; there is no co-payment on the Major CI, Minor CI, ICU, or maturity benefits. Mis-stating this either way is mis-selling.

  2. 136-condition headline overstatement. The brochure says “136 conditions” but the 58 Minor + 1 Angioplasti payouts accelerate against the same Major SA. A customer who hears “136 conditions” and pictures 136 separate full payouts has been mis-sold. Always explain the accelerated structure in writing on the SPAJ (Surat Pengajuan Asuransi Jiwa).

  3. ICU benefit qualifier. The ICU daily cash and ICU catch-all pay only when the insured requires invasive ventilation (endotracheal tube or tracheostomy). CPAP, BiPAP, masker, and any non-invasive ventilation are explicitly excluded. A meaningful share of real-world ICU admissions do not involve invasive ventilation. Customers who expect “any ICU stay = paid” will complain. Document the qualifier in writing.

  4. 80-day waiting period misalignment with customer urgency. The CI benefit set is excluded during the first 80 calendar days from inception or reinstatement. Customers with a pending diagnostic appointment, recent symptom, or family history pressure who are buying because something happened recently are by definition in the wrong product. Walk through the waiting clause explicitly and decline the case if there is any signal of a pending medical event the customer has not disclosed.

  5. Pre-existing conditions exclusion is total for the CI benefit set. Every CI-related payout (Major, Angioplasti, Minor, Minor relapse, ICU daily, ICU catch-all, overseas treatment) is excluded for pre-existing conditions. Hypertension, diabetes, cholesterol, prior cancer, prior cardiac event — even if undiagnosed but symptomatic. Non-disclosure on the SPAJ is the most common reason for AIA CI claim repudiation. Agents must walk the customer through the pre-existing exclusion in plain language and document the disclosure conversation.

  6. Vitality cashback headline vs reality. The brochure shows up to 30% annual cashback at Platinum on a 20-year PPT. Platinum status is genuinely hard to maintain year over year — the realistic median customer settles at Silver (2.5–7.5% Year-1 discount + 2.5–7.5% annual cashback). Quoting the 30% headline as if it is the expected value is mis-selling. Quote the Silver/Gold scenario as the base case and Platinum as the upside.

  7. Currency and overseas-treatment expectations. The overseas treatment benefit pays in IDR up to 50% SA plus USD 200/day pocket money. Customers should not assume “go to Singapore for treatment, AIA pays everything” — the cap is 50% SA, the trigger is post-Major-CI claim only, and the 12-month window means treatment must be initiated promptly. Walk the customer through a Rp 500M SA scenario: Rp 250M is the overseas treatment cap, which covers a typical Mt Elizabeth cancer protocol partially but not fully. Set the expectation correctly.


Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.

Expert · technical detail

Raw fields

Entity type
conventional
Channel
agency
Category
critical-illness
Benchmark carrier
no
Extraction quality
pdf-downloaded
First cataloged
2026-04-24
Last updated
2026-05-17
Brief date
2026-05-17
Analyst confidence
Medium — both primary documents present and consistent, product mechanics fully readable; category-level competitor benchmarks are qualitative because the CI segment has not yet reached the 60% PDF-coverage threshold.

Source documents

On-disk (read-only upstream):
documents/aia-indonesia/conventional/proteksi-penyakit-kritis-maksima-ekstra-prima-extra/riplay-2026-04-29.pdf
documents/aia-indonesia/conventional/proteksi-penyakit-kritis-maksima-ekstra-prima-extra/brochure-2026-04-29.pdf

Insurer product page ↗

How Critical Illness products differ

Still building · 77% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

  • Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
  • Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
  • Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
  • Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
  • TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.

Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)

Expert · full Strategic Brief

1. The 60-Second Pitch

Prima Extra is a bank-channel critical-illness lump-sum policy that doubles as a long-dated whole-of-life contract — pay premiums for 5, 10, or 20 years, get protection to age 99, and walk away with a 100% Uang Pertanggungan (sum assured) endowment if you survive the term. The structural hook is breadth: 136 catalogued conditions split across 77 Major (100% SA payout, terminates the policy) and 58 Minor (25% SA payout, accelerates against the Major) plus an Angioplasti surgical benefit (25% SA, capped at Rp 250M). Three features differentiate it from the lump-sum CI pack: (1) a minor-cancer relapse benefit that re-pays 25% SA if a second, histologically distinct cancer appears more than 12 months after the first minor-cancer claim; (2) overseas treatment cover for cancer/heart conditions up to 50% SA in the 12 months after a Major claim, with USD 200/day pocket money plus transport and accommodation; and (3) a maturity benefit — if the insured reaches age 99 with no Major claim and no full SA paid out, the residual SA is returned. The Vitality program layer adds 2.5–7.5% Year-1 premium discount and up to 30% annual cashback at Platinum status. In one line: a long-horizon CI lump-sum policy with a survival payout, sold through BCA, that rewards healthy living and treats cancer recurrence as a separately payable event.


2. Headline Numbers Decoded (the brochure sample case)

The brochure illustrates Donny, age 35, buying for his wife Sarah, age 30, Rp 500M sum assured, 10-year payment term, with both Payor Benefit and Payor Benefit CI riders attached. Decoded:

Critical insight for the agent narrative: the headline 136-condition figure is a count, not a value. The 58 Minor conditions and the Angioplasti each pay 25% SA — they accelerate against the same Major SA, so a policyholder cannot stack them to a sum higher than 100% SA. The single biggest economic feature is the Major CI payout combined with the 12-month post-claim overseas treatment window — uncommon outside HNW-tier CI products.


SUM ASSURED

Rp 500,000,000

The headline number every

benefit references as % of SA.

ANNUAL BASE PREMIUM

Rp 17,856,000

Before riders, before Vitality

discount.

RIDER PREMIUM

Rp 508,539

Payor Benefit + Payor Benefit

CI combined.

TOTAL ANNUAL PREMIUM

Rp 18,364,539

Pre-Vitality.

YEAR-1 PREMIUM PAID

(with Vitality 5% discount)

Rp 17,471,739

Year 1 only. Excludes Vitality

membership fee.

TOTAL 10-YEAR PREMIUM

~Rp 183.6M

Without Vitality discount

(nominal, undiscounted).

PREMIUM-TO-SA RATIO

~36.7% of SA over 10 years

Sarah hands AIA ~Rp 184M;

the headline cover is Rp 500M.

ANGIOPLASTI BENEFIT

25% SA = Rp 125M

Cap is the lower of 25% SA or

Rp 250M — Rp 125M binds here.

MINOR-CANCER BENEFIT

25% SA = Rp 125M

One-shot, accelerates against

Major SA.

MINOR-CANCER RELAPSE

25% SA = Rp 125M

Only if histologically

distinct, >12 months later,

different organ.

MAJOR-CI BENEFIT (CANCER/HEART)

100% SA = Rp 500M

Policy stays live 12 months

longer so overseas treatment

cover can apply.

OVERSEAS TREATMENT (CANCER/HEART)

Up to 50% SA = Rp 250M

Triggers only after Major CI

claim. USD 200/day allowance

plus transport & accommodation.

DEATH BENEFIT (NON-CI)

100% SA = Rp 500M

Net of accelerated payouts

already drawn.

ACCIDENTAL-DEATH ADD-ON

100% SA = Rp 500M

Stacks on top of remaining SA.

ICU DAILY CASH

Rp 5M/day, max 20 days

Days 1–4 of qualifying ICU

stay with invasive ventilation.

ICU CATCH-ALL

50% SA, capped Rp 250M

Day 5+ continuous ICU with

invasive ventilation.

One shot, accelerated.

MATURITY BENEFIT (AGE 99)

100% SA, net of accelerated

payouts. The survival

payback.

3. Ideal Customer Profile

Sweet Spot — Lead with Prima Extra (if you’re an AIA/BCA-channel agent)

  • Age 30–50, BCA primary banking relationship, comfortable with autodebet from BCA savings or BCA credit card
  • Household income Rp 15M+/month; needs to support the minimum Rp 500,000/month premium ticket on a meaningful SA
  • Wants lump-sum critical-illness protection (not health reimbursement) — already has a hospital-cash or health plan separately
  • Family cancer or heart-disease history → values the overseas-treatment window and the relapse benefit
  • Lifestyle that earns Silver/Gold/Platinum Vitality status — runners, gym regulars, smart-watch users. Without Vitality engagement the cashback math doesn’t move.
  • Long horizon — sees insurance as a 20-year, age-to-99 commitment, not a 5-year hedge

Borderline Fit — Discuss but qualify carefully

  • Age 51–60 — still eligible, but Premi/SA ratio worsens sharply; only 5-year PPT available at 56–60, which loads the cashflow heavily
  • Customers who want CI cover but bank with Mandiri/BNI/BRI — Prima Extra is BCA-channel; they will need to open a BCA account or pay by BCA credit card for the autodebet
  • Parents buying for children (1 month – 17 years) — works, but the 20% SA payout for diagnoses in the first 90 days post-birth (180 days for death) is an under-discussed dilution most parents miss
  • Customers who already own a Major CI lump-sum policy elsewhere — Prima Extra can layer for the relapse + overseas treatment angle, but is not a clean primary policy stack

Do Not Pitch

  • Customers looking for medical reimbursement / hospital cashless — wrong product. Prima Extra pays a lump sum on diagnosis; it does not pay hospital bills directly except for the ICU daily cash and ICU catch-all (which trigger only with invasive ventilation, not standard ICU stays).
  • Customers without basic hospital cover — sell them a medical plan first
  • Customers without USD financial relevance who can’t afford the Rp 500K/month minimum — there is no entry-level skinnier variant
  • Anyone uncomfortable with the 80-day waiting period on the CI benefit set — if they’re shopping because they recently had a worrying symptom, this is mis-selling territory
  • Customers with pre-existing conditions they have not disclosed — the entire CI benefit set is excluded for pre-existing conditions; non-disclosure creates a repudiation risk

4. Decision Framework — When Prima Extra Beats the Alternatives

This is for Legacy Income agents who sell Allianz Smart Critical Illness Protection (Smart CI) and Tokio Marine CI products. The competitor is on a BCA customer’s shortlist; the question is when to fight, when to defer, when to redirect.

Rule of thumb: if the customer’s first sentence contains “kanker” (cancer), “kambuh” (relapse), “berobat ke luar negeri” (overseas treatment), or “BCA” — Prima Extra belongs in the shortlist. If their first sentence contains “rawat inap” (hospitalisation), “kamar rumah sakit” (hospital room), “cashless”, or “Mandiri/BNI” — redirect to a hospital plan or a non-BCA channel CI.


PROSPECT IS BCA-PRIMARY, WANTS CI LUMP-SUM, MODEST SA

Lead:Prima Extra

Distribution moat; autodebet from BCA is frictionless; rivals can't match same-bank UX.

PROSPECT BANKS ELSEWHERE, WANTS COMPREHENSIVE CI

Lead:Allianz Critical+ or Tokio Marine CI

Agency distribution removes the BCA-account friction; rate sheet often competitive at same SA.

PROSPECT VALUES SURVIVAL PAYBACK (RETURN OF SA AT 99)

Lead:Prima Extra

Endowment-style maturity benefit is uncommon in the lump-sum CI peer set.

PROSPECT WANTS CI CASH AND PERMANENT LIFE COVER IN ONE WRAPPER

Lead:Allianz LegacyPro + Critical+ rider

Whole-life chassis with CI premium waiver; cleaner legacy positioning; short-pay flexibility.

PROSPECT'S CONCERN IS CANCER RECURRENCE

Lead:Prima Extra

Minor-cancer relapse pays 25% SA again if histologically distinct >12 months later — peer set rarely codifies this.

PROSPECT IS WEALTHY, WANTS OVERSEAS TREATMENT AS A PRIMARY USE CASE

Lead:Prima Extra (or Tokio Marine equivalent if BCA friction is real)

Overseas treatment benefit (up to 50% SA + USD 200/day) is one of the cleaner formulations in Indonesian CI market.

PROSPECT WANTS LOWEST PREMIUM FOR CI COVER

Lead:Term-CI rider on existing life policy

Prima Extra's whole-of- life chassis loads premium; pure term-CI is 3-5x cheaper per Rp of SA.

PROSPECT IS A FITNESS ENTHUSIAST, USES WEARABLES

Lead:Prima Extra

Vitality cashback is the only mechanism in Indonesian market that monetises Platinum-tier fitness — up to 30%/yr cashback on 20-year PPT.

PROSPECT IS RISK-AVERSE TO INVESTMENT-LINKED

Lead:Prima Extra (it's traditional, not ULIP)

No fund choice, no market exposure; structurally closer to whole-life.

PROSPECT HAS PRE-EXISTING CONDITIONS, SHORT HORIZON

Lead:Walk away

80-day waiting period + pre-existing exclusion block the use case; guaranteed mis-sell.

5. Product Benchmarking — Prima Extra vs the Critical-Illness Category

The Indonesian critical-illness category in our catalogue is 26 products across multiple insurers, 23 with PDFs extracted. It is structurally heterogeneous: traditional lump-sum CI (Prima Extra type), early-stage CI riders, gender-specific CI, recurring-payout CI, ULIP-attached CI, and pure CI premium-waiver mechanics. Quantitative coverage is below the 60% category threshold — the benchmarking below is descriptive and qualitative.

Confidence note: structural-dimension claims are high-confidence (drawn directly from the RIPLAY and brochure). Category comparisons reflect analyst judgment from catalogue knowledge, not parsed competitor RIPLAYs. Refresh trigger: re-run when critical-illness category PDF coverage exceeds 60%, especially Allianz Critical+, Manulife MiSmart CI, Prudential PRUTotal CritiCare, and BNI Life CI products.


STRUCTURAL DIMENSIONS

COVERAGE HORIZON

Category typical:To age 70–88

Prima Extra:To age 99

Read:Among the longest in category. Many lump-sum CI products cap at 70 or 85. Closer to whole-life than pure-term CI.

PREMIUM PAYMENT TERM

Category typical:To-age level or 5/10/15 short-pay

Prima Extra:5/10/20 yrs

Read:20-year PPT is unusual — most short-pay CI tops at 15 years. Stretches premium load but extends Vitality cashback window.

ENTRY AGE WINDOW

Category typical:17 or 18 – 60 or 65

Prima Extra:1 month – 60

Read:Newborn-eligible — sets up the unborn-child benefit (one of few CI products that underwrites in utero).

NUMBER OF CI CONDITIONS

Category typical:50–100 for Major; sometimes 100+ when Minor is bolted on

Prima Extra:77 Major + 58 Minor + 1 angioplasti = 136

Read:Top-quartile breadth. But beware count inflation — the 58 Minor and angioplasti each accelerate against the same Major SA, so total payout cap is 100% SA, not 136-condition × full payout.

MINOR-CANCER RELAPSE

Category typical:Almost none codify a second-cancer payout

Prima Extra:25% SA, one shot, distinct histology

Read:Differentiated. Strong pitch for customers with family cancer history.

OVERSEAS TREATMENT

Category typical:Rarely bundled; usually a paid rider or HNW-tier product only

Prima Extra:Up to 50% SA + USD 200/day + transport & accommodation, post-Major-CI diagnosis, 12-month window

Read:One of the stronger overseas-treatment formulations in the catalogue.

MATURITY BENEFIT

Category typical:Pure-CI products often have no maturity payout; many ULIP variants do

Prima Extra:100% SA at age 99 if no Major claim

Read:Endowment-style return of cover; rare in traditional CI. Material for the conservative segment that hates "wasted premium".

ICU MECHANIC

Category typical:Daily cash or lump sum, often weak qualifiers

Prima Extra:Rp 5M/day for days 1–4 OR 50% SA (cap Rp 250M) for day 5+ — only with invasive ventilation (endotrach/tracheostomy)

Read:Strict qualifier. Many ICU stays are non-invasive (CPAP/BiPAP) and excluded. Customer will misread this as "ICU = paid"; agent must flag.

UNBORN CHILD BENEFIT

Category typical:Rare

Prima Extra:Yes (limits

apply:one foetus per policy)

Read:Niche differentiator.

VITALITY PROGRAM

Category typical:Rare in conventional CI; more common on health

Prima Extra:Yes — 2.5/5/ 7.5% Year-1 discount + up to 10/20/30% annual cashback (5/10/20-yr PPT, Platinum status)

Read:Strongest cashback-led CI play in the catalogue. Requires sustained Platinum status to deliver headline %.

ECONOMIC DIMENSIONS

PREMIUM ENTRY POINT

Category typical:Wide; some entry at Rp 200K/month

Prima Extra:Min Rp 500K/ month

Read:Filters mass-market entry. Mid-market upward.

PREMIUM-TO-SA RATIO (10y PPT,

F30, Rp 500M SA, sample case)

Category typical:25–40% of SA over PPT for comparable CI

Prima Extra:~36–37% over 10y (Sarah sample case, pre-Vitality, pre-rider)

Read:Mid-range. Not cheap, not expensive. Vitality cashback can pull effective rate down 5–10% over PPT if customer hits Gold or Platinum consistently.

SURRENDER VALUE

Category typical:Weak early, ramps slowly

Prima Extra:Nilai Tunai exists (referenced in Pinjaman Premi Otomatis and Pinjaman Polis clauses) but tabel is not in the RIPLAY.

Read:Treat as low-disclosure. Need full polis for actual Faktor Penebusan table.

POLICY LOAN

Category typical:Available on whole-life style products

Prima Extra:Yes — both Pinjaman Polis (cash value loan) and Pinjaman Premi Otomatis (auto-loan from cash value when premium lapses)

Read:Useful customer protection if Sarah hits cash-flow stress.

POSITIONING SUMMARY

Prima Extra sits in the

TOP-DECILE for STRUCTURAL CI

breadth in the catalogue —

136-condition count, minor-

cancer relapse, overseas

treatment, age-99 horizon,

maturity benefit, Vitality

program. It is one of the

most feature-rich lump-sum

CI products in the Indonesian

market.

Prima Extra sits MID-PACK on

PRICE — the premium ratio is

not aggressive; the value

comes from feature breadth

plus the Vitality cashback,

not from cheap base rates.

The structural moats are

(1) BCA distribution

(frictionless autodebet,

in-branch lead flow);

(2) overseas-treatment cover

bundled in base policy;

(3) Vitality cashback being

one of the strongest in

Indonesian conventional CI;

(4) endowment-style maturity

payout in a CI wrapper.

Vulnerabilities versus the

Allianz / Tokio Marine peer

set

(1) BCA-channel only — agency

competitors win every

non-BCA prospect by

default;

(2) ICU qualifier (invasive

ventilation only) is

narrow; will surprise

customers who expect any

ICU stay to pay;

(3) Vitality headline cashback

requires sustained Platinum

status that most customers

will not reach;

(4) No explicit Faktor

Penebusan table in RIPLAY

— opacity on early-year

surrender economics is

a fair customer concern.

6. Field Talking Points (EN + ID)

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Opening — frame the right problem

“Most people buy critical-illness cover because they’re afraid of the diagnosis. The actual problem is bigger: it’s the year after the diagnosis — when you can’t work, you’re paying for treatment, and your family income drops. What I want to talk about is how to handle that year, not the diagnosis itself.”

“Kebanyakan orang beli asuransi penyakit kritis karena takut dengan diagnosanya. Padahal masalah sesungguhnya lebih besar: setahun setelah diagnosa — saat Anda tidak bisa kerja, biaya pengobatan jalan terus, dan pemasukan keluarga turun. Yang ingin saya bahas adalah bagaimana menghadapi tahun itu, bukan diagnosanya sendiri.”

Structural value prop — the three things that matter

“Three things in this policy that I want you to understand. First, the major CI list is broad — 77 conditions paying 100% of your cover, plus 58 minor conditions paying 25%. Second, if you’re diagnosed with cancer or a major heart condition, the policy stays alive for 12 more months so we can fund overseas treatment up to half your sum assured, including USD 200 per day pocket money and transport. Third, and this is unusual, if you have a minor cancer claim and then a completely different type of cancer appears more than a year later, we pay another 25% — most products treat the first cancer claim as the end of the story.”

“Tiga hal di polis ini yang harus Anda pahami. Pertama, daftar penyakit kritis luas — 77 kondisi Major bayar 100% Uang Pertanggungan, plus 58 kondisi Minor bayar 25%. Kedua, kalau Anda terdiagnosa kanker atau jantung Major, polis tetap aktif 12 bulan supaya kita bisa biayai pengobatan ke luar negeri sampai setengah Uang Pertanggungan, termasuk uang saku USD 200 per hari plus transport. Ketiga, dan ini jarang — kalau Anda klaim Kanker Minor lalu setahun kemudian muncul jenis kanker yang benar-benar berbeda, kami bayar 25% lagi. Kebanyakan produk anggap klaim kanker pertama sudah selesai.”

The Vitality hook (only if the customer is actually active)

“There’s a separate program called Vitality. If your wife is the type who runs, goes to the gym, tracks her steps on her watch — Vitality rewards that. At Platinum status on a 20-year payment plan, you can get back 30% of your premium every year as cashback. I’m not going to oversell this — most customers settle at Silver or Gold. But if she’s already active, the math becomes interesting.”

“Ada program terpisah namanya Vitality. Kalau istri Anda tipe yang rajin lari, ke gym, tracking langkah di jam tangan — Vitality memberi reward untuk itu. Di status Platinum dengan masa bayar 20 tahun, cashback bisa sampai 30% premi per tahun. Saya tidak mau over-sell — kebanyakan nasabah berhenti di Silver atau Gold. Tapi kalau memang aktif, hitungan jadi menarik.”

The maturity / survival hook (the “you get something back” frame)

“If you reach age 99 without ever claiming the major benefit, we return the full sum assured. Most CI policies pay nothing if you stay healthy — your premium is gone, which is the trade-off for protection. This one returns the cover at maturity. Whether that matters to you depends on your view: are you buying insurance, or are you buying long-term capital with insurance attached?”

“Kalau Anda sampai usia 99 tanpa pernah klaim manfaat Major, kami kembalikan 100% Uang Pertanggungan. Kebanyakan polis CI tidak bayar apa-apa kalau Anda tetap sehat — preminya hilang, itu konsekuensi proteksi. Yang ini kembalikan cover-nya di akhir masa asuransi. Apakah ini penting buat Anda tergantung cara pandang: Anda beli asuransi, atau Anda beli simpanan jangka panjang dengan proteksi nempel?”

Close — pick the structure

“Three decisions tonight. First, sum assured — anything from Rp 100 juta to Rp 10 miliar. I usually recommend 3 to 5 times annual income for CI. Second, payment term — 5, 10, or 20 years. The longer the term, the lower the annual premium but the longer Vitality cashback runs. Third, Vitality yes or no. If you’re already active, yes. If not, no. We can finalise all three over the next 15 minutes.”

“Tiga keputusan malam ini. Pertama, Uang Pertanggungan — dari Rp 100 juta sampai Rp 10 miliar. Saya biasanya rekomendasi 3 sampai 5 kali penghasilan tahunan untuk CI. Kedua, masa pembayaran premi — 5, 10, atau 20 tahun. Makin lama, premi tahunan makin ringan tapi Vitality cashback jalan lebih lama. Ketiga, Vitality ya atau tidak. Kalau memang aktif, ya. Kalau tidak, tidak usah. Kita finalisasi ketiganya dalam 15 menit ke depan.”

7. Top 5 Customer Objections + Handling

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

1. “BPJS already covers serious illness — why pay extra?”

Customer “BPJS already covers serious illness. Why do I need this on top?”

Customer “BPJS kan sudah cover penyakit berat. Kenapa saya butuh ini lagi?”

Don't say “BPJS is bad.”

Don't say “BPJS itu jelek.”

Do say “BPJS pays the hospital — directly, on your behalf, for whatever the formulary allows, at whatever hospital is in the BPJS network. This product pays you, in cash, the moment you’re diagnosed — Rp 500 juta in the sample case. That cash covers the things BPJS doesn’t pay for: lost income while you can’t work, the household running costs, the gap between the BPJS treatment plan and what your specialist actually recommends, and the option to go overseas for treatment if needed. Different problem, different tool.”

Do say “BPJS bayar rumah sakit — langsung, atas nama Anda, sesuai formularium, di rumah sakit yang masuk jaringan BPJS. Produk ini bayar Anda — tunai — begitu Anda terdiagnosa. Di contoh tadi Rp 500 juta. Uang tunai itu menutupi yang BPJS tidak bayar: pemasukan yang hilang saat Anda tidak bisa kerja, biaya rumah tangga jalan terus, selisih antara plan pengobatan BPJS dengan yang sebenarnya dokter spesialis rekomendasikan, dan opsi berobat ke luar negeri kalau perlu. Masalahnya beda, alatnya juga beda.”

2. “Premium will go up every year — I can’t commit.”

Customer “Premium for these things always goes up. I can’t commit to 20 years.”

Customer “Premi gini-gini selalu naik. Saya nggak bisa commit 20 tahun.”

Don't say “Premium will not go up.”

Don't say “Premi tidak naik kok.”

Do say “This is a traditional product, not a unit-linked. The base premium is fixed for the entire payment term you choose — 5, 10, or 20 years. There is no annual repricing on the base. The only variable element is the Vitality cashback, which moves in your favour the more active you are. The 20-year term gives you the lowest annual premium; the 5-year term gives you the fastest paid-up status. If commitment is the worry, take the 5-year term and the smaller SA — pay it off in five years, you’re done, the cover runs another 60+ years.”

Do say “Ini produk tradisional, bukan unit-linked. Premi dasarnya fixed selama masa pembayaran yang Anda pilih — 5, 10, atau 20 tahun. Tidak ada penyesuaian tahunan di premi dasar. Satu-satunya yang variable adalah cashback Vitality, dan itu bergerak menguntungkan Anda kalau makin aktif. Masa 20 tahun memberi premi tahunan paling ringan; masa 5 tahun memberi paid-up paling cepat. Kalau commitment yang jadi kekhawatiran, ambil masa 5 tahun dengan UP lebih kecil — lima tahun selesai, cover-nya jalan 60+ tahun lagi.”

3. “I’m healthy, my family doesn’t have cancer. Why now?”

Customer “I’m healthy and there’s no cancer in my family. Why now?”

Customer “Saya sehat dan keluarga tidak ada riwayat kanker. Kenapa harus sekarang?”

Don't say “Because you might get cancer.”

Don't say “Karena Anda bisa kena kanker.”

Do say “Two reasons. First, premium is set by the age you enrol — every year you wait, the premium for the same cover goes up significantly. Buying at 35 versus 45 is a different price point for life. Second, the 80-day waiting period applies from the day the policy starts. If you wait until you have a worrying symptom to buy, the underwriter will either decline or attach exclusions. The window to buy clean cover is when you don’t need it — that’s now.”

Do say “Dua alasan. Pertama, premi ditentukan oleh umur Anda saat daftar — setiap tahun ditunda, premi untuk cover yang sama naik signifikan. Beli umur 35 versus 45 itu beda price point untuk seumur hidup. Kedua, masa tunggu 80 hari berlaku dari tanggal polis dimulai. Kalau Anda menunggu sampai ada gejala yang mengkhawatirkan baru beli, underwriter akan tolak atau pasang exclusion. Waktu paling tepat beli cover bersih adalah saat Anda belum butuh — yaitu sekarang.”

4. “If I claim 25% for the angioplasty and 25% for minor cancer, that’s 50% — only 50% left for the major event?”

Customer “If I use the angioplasty benefit and the minor cancer benefit, I lose 50% of my cover for any future major illness?”

Customer “Kalau saya pakai manfaat angioplasti dan kanker minor, berarti cover untuk penyakit besar nanti tinggal 50%?”

Don't say “No, you still get 100%.”

Don't say “Nggak kok, masih tetap 100%.”

Do say “Yes — you’ve read the structure correctly, and this is important for me to be honest about. The minor and angioplasty payouts are ‘accelerated’ — they accelerate against the major SA and reduce it. The trade-off is intentional: you get cash early when you need it for the minor event, in exchange for less cover later if a major event happens. Two things to know: first, the major cancer or heart event still keeps the policy active for 12 months for overseas treatment even after the major payout. Second, the minor-cancer relapse benefit is a fresh 25% — that one does not accelerate against the major. So the structure rewards getting cash early when you need it, and gives you a relapse cushion for cancer specifically.”

Do say “Betul — Anda baca strukturnya dengan benar, dan ini penting saya jujur. Pembayaran minor dan angioplasti sifatnya akselerasi — mengurangi Uang Pertanggungan Major. Trade-off-nya disengaja: Anda dapat uang tunai lebih cepat saat butuh untuk kondisi minor, sebagai gantinya cover untuk kondisi besar nanti berkurang. Dua hal yang perlu Anda tahu: pertama, klaim kanker atau jantung Major tetap memperpanjang polis 12 bulan untuk pengobatan luar negeri, walaupun pembayaran Major sudah keluar. Kedua, manfaat pembaruan Kanker Minor itu 25% segar — yang itu tidak akselerasi terhadap Major. Jadi strukturnya memberi reward untuk dapat uang cepat saat butuh, dan kasih bantalan khusus untuk kekambuhan kanker.”

5. “I bank with Mandiri, not BCA. Can I still buy this?”

Customer “I’m a Mandiri customer, not BCA. Can I still get this policy?”

Customer “Saya nasabah Mandiri, bukan BCA. Apa masih bisa beli polis ini?”

Don't say “You have to open a BCA account.”

Don't say “Anda harus buka rekening BCA dulu.”

Do say “Honest answer: Prima Extra is sold through BCA — premium is autodebited from a BCA savings account or BCA credit card. If you don’t bank with BCA, there’s friction. Two paths: open a BCA account specifically for this autodebet, which adds an account and a bit of admin; or, look at a comparable CI product from an agency channel that takes any bank’s autodebet — Allianz Critical+ or a Tokio Marine CI product. I can show you both side by side if you’d like — the goal is to match the cover to your bank reality, not the other way around.”

Do say “Jujur ya — Prima Extra dijual lewat BCA, premi auto-debit dari rekening tabungan BCA atau kartu kredit BCA. Kalau Anda bukan nasabah BCA, ada friksi. Dua opsi: buka rekening BCA khusus untuk auto-debit ini, yang artinya nambah rekening dan sedikit admin; atau lihat produk CI sejenis dari channel agency yang terima auto-debit dari bank manapun — Allianz Critical+ atau produk Tokio Marine CI. Saya bisa kasih bandingannya berdampingan kalau Anda mau — tujuannya cocokkan cover dengan kondisi bank Anda, bukan sebaliknya.”

8. Compliance Red Flags & Mis-Selling Warnings

These are the issues most likely to trigger an OJK complaint or a customer dispute in 2026 under the tightened bancassurance conduct rules. Build agent training around all seven.

  1. POJK 36/2025 co-payment context. POJK 36/2025 brought a 10% co-payment regime into Indonesian health insurance from 2026. Prima Extra is not a health/reimbursement product — it is a lump-sum CI policy, so the co-payment regime does not apply to its benefit payouts. However, BCA frontline staff may incorrectly mention co-payment when describing the product because the BCA training materials cover both health and CI lines. Agents must explicitly correct: Prima Extra pays a defined cash sum on diagnosis; there is no co-payment on the Major CI, Minor CI, ICU, or maturity benefits. Mis-stating this either way is mis-selling.

  2. 136-condition headline overstatement. The brochure says “136 conditions” but the 58 Minor + 1 Angioplasti payouts accelerate against the same Major SA. A customer who hears “136 conditions” and pictures 136 separate full payouts has been mis-sold. Always explain the accelerated structure in writing on the SPAJ (Surat Pengajuan Asuransi Jiwa).

  3. ICU benefit qualifier. The ICU daily cash and ICU catch-all pay only when the insured requires invasive ventilation (endotracheal tube or tracheostomy). CPAP, BiPAP, masker, and any non-invasive ventilation are explicitly excluded. A meaningful share of real-world ICU admissions do not involve invasive ventilation. Customers who expect “any ICU stay = paid” will complain. Document the qualifier in writing.

  4. 80-day waiting period misalignment with customer urgency. The CI benefit set is excluded during the first 80 calendar days from inception or reinstatement. Customers with a pending diagnostic appointment, recent symptom, or family history pressure who are buying because something happened recently are by definition in the wrong product. Walk through the waiting clause explicitly and decline the case if there is any signal of a pending medical event the customer has not disclosed.

  5. Pre-existing conditions exclusion is total for the CI benefit set. Every CI-related payout (Major, Angioplasti, Minor, Minor relapse, ICU daily, ICU catch-all, overseas treatment) is excluded for pre-existing conditions. Hypertension, diabetes, cholesterol, prior cancer, prior cardiac event — even if undiagnosed but symptomatic. Non-disclosure on the SPAJ is the most common reason for AIA CI claim repudiation. Agents must walk the customer through the pre-existing exclusion in plain language and document the disclosure conversation.

  6. Vitality cashback headline vs reality. The brochure shows up to 30% annual cashback at Platinum on a 20-year PPT. Platinum status is genuinely hard to maintain year over year — the realistic median customer settles at Silver (2.5–7.5% Year-1 discount + 2.5–7.5% annual cashback). Quoting the 30% headline as if it is the expected value is mis-selling. Quote the Silver/Gold scenario as the base case and Platinum as the upside.

  7. Currency and overseas-treatment expectations. The overseas treatment benefit pays in IDR up to 50% SA plus USD 200/day pocket money. Customers should not assume “go to Singapore for treatment, AIA pays everything” — the cap is 50% SA, the trigger is post-Major-CI claim only, and the 12-month window means treatment must be initiated promptly. Walk the customer through a Rp 500M SA scenario: Rp 250M is the overseas treatment cap, which covers a typical Mt Elizabeth cancer protocol partially but not fully. Set the expectation correctly.


9. Quick-Reference Spec Card


BASIC

Product

Proteksi Penyakit Kritis

Maksima Extra (PRIMA Extra)

Type

Traditional whole-life CI

(lump-sum + maturity)

Insurer

PT AIA FINANCIAL

Channel

Bancassurance — Bank BCA

(autodebet BCA tabungan

or BCA credit card)

Currency

IDR

RIPLAY code

RP120R11-1125

Doc dates

RIPLAY + brochure

downloaded 2026-04-29

TERMS

Pay terms

5 / 10 / 20 years

(cannot change mid-policy)

Entry age

Insured:1 month – 60 yrs (5y PPT to age 60; 10y PPT to age 55; 20y PPT to age 50)

Policyholder:18+ (min)

Coverage

To age 99

Min SA

Rp 100,000,000

Max SA

Child (1mo–17y): Rp 3,000,000,000 Adult (18+): Rp 10,000,000,000

Min premium

Rp 500,000/month

Pay freq

Annual / semi-annual /

quarterly / monthly

(autodebet BCA)

BENEFITS

Major CI

77 conditions, 100% SA

(less accelerated)

Minor CI

58 conditions, 25% SA

(one-shot, accelerates)

Angioplasti

25% SA or Rp 250M,

whichever lower (one-shot,

accelerates)

Minor-Ca 25% SA, fresh (does NOT

relapse

accelerate against Major).

Distinct histology,

different organ,

>12 months later. One shot.

Death

100% SA (less accelerated)

Accidental +100% SA on top of any

death rider

remaining SA

ICU daily

Rp 5M/day, days 1–4,

max 20 days lifetime,

invasive ventilation only

ICU catch 50% SA or Rp 250M,

all

day 5+ continuous,

invasive ventilation only

(one-shot, accelerates)

Overseas tx

Up to 50% SA + USD 200/day

(Major Ca + transport & accommodation

or Heart)

Triggered post-Major-CI

claim; 12-month window.

Unborn For 1 child in utero

child

per policy. Mother is

temp insured weeks 18–36.

20% SA payouts in first

90 / 180 days of life

(per benefit).

Maturity

100% SA at age 99

(akhir (less accelerated)

polis)

WAITING PERIODS

CI benefits

80 days from inception

or reinstatement

Accidental None (immediate from

death rider

inception)

EXCLUSIONS NOTABLE

Pre-existing conditions

(full CI benefit set)

HIV / AIDS / ARC

(CI set; carve-outs for HIV-

related CI as listed in

polis annex)

Suicide / self-harm

(death benefit)

Motorsport, illegal flight

(accidental-death rider)

Non-invasive ventilation

(excluded from ICU benefits)

POLICY MECHANICS

Grace period

45 cal days from

premium due date

Free look

14 cal days from

policy receipt

Reinstatement

Within 2 years from

last premium due

date; medical exam

may be required

Premium loan

Auto-loan from cash

(Pinjaman Premi value if premium

Otomatis) unpaid past grace;

compound interest

Policy loan

Available against

(Pinjaman Polis) cash value; compound

interest, rate per

AIA website

Vitality

Year-1 premium

discount 2.5/5/7.5%

(5/10/20-y PPT)

Annual cashback:Bronze 0% Silver 2.5/5/7.5% Gold 5/10/15% Platinum 10/20/30% (matched to PPT)

SAMPLE CASE (BROCHURE)

Donny (35m) buying for Sarah (30f)

Rp 500M SA, 10-year PPT

Base premium

Rp 17,856,000

Rider premium

Rp 508,539

Total annual

Rp 18,364,539

Year-1 w/ Vitality

Rp 17,471,739

(5% Year-1 discount on base)

Excludes Vitality membership fee.

10. Action Items for Legacy Income (next 30 days)

Prima Extra is a competitor product on BCA-channel customers’ shortlists. Legacy Income agents need a defensible play for each of the five customer states most likely to come up.

  1. Build a “Prima Extra vs Allianz Critical+ vs Tokio Marine CI” one-pager in EN+ID. Three columns, six rows: SA range, premium ticket per Rp 1M SA at age 35/45, condition count and acceleration structure, overseas-treatment formulation, ICU qualifier, channel friction. Use this as the leave-behind when a BCA customer mentions they’re considering Prima Extra. The Prima Extra column should be honest — show the strengths (overseas treatment, relapse benefit, Vitality cashback) as well as the weaknesses (BCA-only channel, ICU invasive-ventilation qualifier, 25% accelerated structure dilutes Major SA).

  2. Field-script the “BCA customer who wants CI” play. When a Legacy Income prospect says “BCA agent showed me Prima Extra last week” — the agent’s first move is not to argue against Prima Extra. The first move is to ask three qualifying questions: (a) Do you have a hospital reimbursement plan separate from this? (If no, sell health first.) (b) Is overseas treatment a realistic use case for you? (If yes, Prima Extra is genuinely strong; the play is to position Tokio Marine CI as a comparable alternative with non-BCA distribution.) © Are you a Vitality/fitness-program user already? (If no, the Prima Extra cashback hook collapses and Allianz Critical+ wins on raw rate.)

  3. Train the “minor cancer relapse” rebuttal. The relapse benefit is the single best Prima Extra differentiator on a clean apples-to-apples basis. Legacy Income agents need a one-paragraph counter: position Allianz Critical+ multi-claim recurrence cover (if applicable in the specific plan variant) or position a layered approach — primary CI from Allianz, secondary cancer-specific cover from Tokio Marine — that delivers comparable recurrence cushion without the BCA-channel lock-in.

  4. Surface the ICU-qualifier gotcha in objection-handling. This is the most exploitable Prima Extra weakness for honest selling. Agents should be able to say, calmly and without disparagement: “Prima Extra’s ICU benefit pays only on invasive ventilation — endotracheal tube or tracheostomy. Standard ICU stays with CPAP or BiPAP don’t trigger. Allianz / Tokio Marine [check specific product] has a broader ICU qualifier. If ICU cover matters to you, this is worth comparing.” Document this with the exact RIPLAY language so agents can quote it accurately.

  5. Refresh trigger and watch list. Re-run this brief against quantitative benchmarks when Indonesian CI category PDF coverage exceeds 60%. Also watch for: (a) AIA Vitality cashback structure changes (any cut in the Platinum tier kills a big chunk of the value proposition); (b) Prima Extra channel expansion beyond BCA (if AIA opens this to agency, the competitive landscape shifts materially for Legacy Income); © POJK guidance updates on lump-sum CI mis-selling — the 136-condition headline and the 30% Vitality cashback headline are both at material risk of being flagged by OJK in 2026–2027.


This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-04-29; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.